Shih Yin Chen

Summary

Affiliation: United BioSource Corporation
Country: USA

Publications

  1. ncbi One-Year Adherence to Warfarin Treatment for Venous Thromboembolism in High-Risk Patients and Its Association with Long-term Risk of Recurrent Events
    Shih Yin Chen
    United BioSource Corporation, 430 Bedford St, Ste 300, Lexington, MA 02420, US
    J Manag Care Pharm 19:291-301. 2013
  2. ncbi Clinical and economic outcomes associated with National Kidney Foundation guideline-concordant oral antidiabetic drug treatment among type 2 diabetes patients with chronic kidney disease
    Shih Yin Chen
    United BioSource Corporation, Lexington, MA, USA
    Curr Med Res Opin 28:493-501. 2012
  3. ncbi National trends in prescribing antidepressants before and after an FDA advisory on suicidality risk in youths
    Shih Yin Chen
    United BioSource Corporation, 430 Bedford St, Lexington, MA 02420, USA
    Psychiatr Serv 62:727-33. 2011
  4. ncbi Opioid utilization and health-care costs among patients with diabetic peripheral neuropathic pain treated with duloxetine vs. other therapies
    Ning Wu
    Health Economic Research and Quality of Life Evaluation, Abt Bio Pharma Solutions, Inc, Lexington, Massachusetts, USA
    Pain Pract 11:48-56. 2011
  5. ncbi Predictors of pain medication selection among patients diagnosed with fibromyalgia
    Luke Boulanger
    United BioSource Corporation, Lexington, Massachusetts, USA
    Pain Pract 12:266-75. 2012
  6. ncbi Caregiver assistance among Medicare beneficiaries with atrial fibrillation and factors associated with anticoagulant treatment
    Shih Yin Chen
    United BioSource Corporation, Lexington, MA, USA
    Am J Geriatr Pharmacother 10:273-83. 2012
  7. ncbi Medical resource use and costs related to central precocious puberty: a retrospective cohort study
    Shih Yin Chen
    United BioSource Corporation, Lexington, Massachusetts 02420, USA
    Endocr Pract 18:519-28. 2012
  8. ncbi Clinical and economic outcomes among hospitalized patients with acute coronary syndrome: an analysis of a national representative Medicare population
    Shih Yin Chen
    United BioSource Corporation, Lexington, MA, USA
    Clinicoecon Outcomes Res 5:181-8. 2013
  9. ncbi Antiepileptic drug treatment patterns and economic burden of commercially-insured patients with refractory epilepsy with partial onset seizures in the United States
    Shih Yin Chen
    United BioSource Corporation, Lexington, MA, USA
    J Med Econ 16:240-8. 2013
  10. ncbi Factors associated with adherence to phosphodiesterase type 5 inhibitors for the treatment of pulmonary arterial hypertension
    Aaron Waxman
    Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    J Med Econ 16:298-306. 2013

Detail Information

Publications12

  1. ncbi One-Year Adherence to Warfarin Treatment for Venous Thromboembolism in High-Risk Patients and Its Association with Long-term Risk of Recurrent Events
    Shih Yin Chen
    United BioSource Corporation, 430 Bedford St, Ste 300, Lexington, MA 02420, US
    J Manag Care Pharm 19:291-301. 2013
    ..Objective: To examine the association between 1-year adherence, measured through compliance with and persistence on warfarin treatment for VTE, and long-term risk of recurrent events among patients at high risk. ..
  2. ncbi Clinical and economic outcomes associated with National Kidney Foundation guideline-concordant oral antidiabetic drug treatment among type 2 diabetes patients with chronic kidney disease
    Shih Yin Chen
    United BioSource Corporation, Lexington, MA, USA
    Curr Med Res Opin 28:493-501. 2012
    ..To assess outcomes associated with oral anti-diabetic drug (OAD) treatment concordant with guidelines from the National Kidney Foundation (NKF) among type 2 diabetes mellitus (T2DM) patients with chronic kidney disease (CKD)...
  3. ncbi National trends in prescribing antidepressants before and after an FDA advisory on suicidality risk in youths
    Shih Yin Chen
    United BioSource Corporation, 430 Bedford St, Lexington, MA 02420, USA
    Psychiatr Serv 62:727-33. 2011
    ..S. Food and Drug Administration advisory linking an increased risk of suicidality with antidepressants among pediatric patients with major depressive disorder...
  4. ncbi Opioid utilization and health-care costs among patients with diabetic peripheral neuropathic pain treated with duloxetine vs. other therapies
    Ning Wu
    Health Economic Research and Quality of Life Evaluation, Abt Bio Pharma Solutions, Inc, Lexington, Massachusetts, USA
    Pain Pract 11:48-56. 2011
    ..This retrospective cohort study assessed subsequent opioid utilization and health-care costs among patients with diabetic peripheral neuropathic pain (DPNP) who initiated duloxetine vs. other standard of care (SOC) treatments...
  5. ncbi Predictors of pain medication selection among patients diagnosed with fibromyalgia
    Luke Boulanger
    United BioSource Corporation, Lexington, Massachusetts, USA
    Pain Pract 12:266-75. 2012
    ..However, the factors associated with each treatment initiation have not been well established. This study assessed factors that were associated with the use of duloxetine vs. other pain medications among patients with fibromyalgia...
  6. ncbi Caregiver assistance among Medicare beneficiaries with atrial fibrillation and factors associated with anticoagulant treatment
    Shih Yin Chen
    United BioSource Corporation, Lexington, MA, USA
    Am J Geriatr Pharmacother 10:273-83. 2012
    ..Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and disproportionately affects the elderly...
  7. ncbi Medical resource use and costs related to central precocious puberty: a retrospective cohort study
    Shih Yin Chen
    United BioSource Corporation, Lexington, Massachusetts 02420, USA
    Endocr Pract 18:519-28. 2012
    ..To evaluate the economic burden of central precocious puberty (CPP) by examining direct health care resource utilization and costs...
  8. ncbi Clinical and economic outcomes among hospitalized patients with acute coronary syndrome: an analysis of a national representative Medicare population
    Shih Yin Chen
    United BioSource Corporation, Lexington, MA, USA
    Clinicoecon Outcomes Res 5:181-8. 2013
    ..To evaluate the clinical and economic burden of acute coronary syndrome (ACS), a common cardiovascular illness, in the Medicare population...
  9. ncbi Antiepileptic drug treatment patterns and economic burden of commercially-insured patients with refractory epilepsy with partial onset seizures in the United States
    Shih Yin Chen
    United BioSource Corporation, Lexington, MA, USA
    J Med Econ 16:240-8. 2013
    ..Conclusions: Pattern of use was very dynamic, suggesting seizures are not well-controlled. Improving seizure control and reducing economic burden of refractory epilepsy remain important unmet medical needs in this population...
  10. ncbi Factors associated with adherence to phosphodiesterase type 5 inhibitors for the treatment of pulmonary arterial hypertension
    Aaron Waxman
    Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    J Med Econ 16:298-306. 2013
    ..The findings suggest that adherence to PDE5Is in patients with PAH is associated with the use of specialty pharmacy, simpler dosing frequency, a lower financial barrier, and a prescription given by pulmonologists...
  11. ncbi Guideline-concordant antidepressant use among patients with major depressive disorder
    Shih Yin Chen
    Abt Bio Pharma Solutions, Inc, Lexington, MA 02421, USA
    Gen Hosp Psychiatry 32:360-7. 2010
    ..To examine whether prescriber specialty and guideline-concordant follow-up visits were associated with antidepressant treatment completion among patients with major depressive disorder (MDD)...
  12. ncbi The relationship between average daily dose, medication adherence, and health-care costs among diabetic peripheral neuropathic pain patients initiated on duloxetine therapy
    Shih Yin Chen
    Health Economic Research and Quality of Life Evaluation, Abt Bio Pharma Solutions, Inc, Lexington, Massachusetts 02451, USA
    Pain Pract 10:530-9. 2010
    ..To examine the relationship between average daily dose (ADD) of duloxetine, adherence to therapy, and health-care costs among patients with diabetic peripheral neuropathic pain (DPNP)...